ID | 47010 |
JaLCDOI | |
フルテキストURL | |
著者 |
Hiraki, Takao
Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
publons
researchmap
Gobara, Hideo
Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
Kaken ID
publons
researchmap
Mimura, Hidefumi
Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Toyooka, Shinichi
Department of Cancer and Thoracic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Fujiwara, Hiroyasu
Department of Diagnostic Radiology, National Cancer Center Hospital
Yasui, Kotaro
Department of Radiology, Okayama Saiseikai General Hospital
Sano, Yoshifumi
Department of Thoracic Surgery, Ehime University Hospital
Iguchi, Toshihiro
Department of Diagnostic Radiology and Interventional Radiology, Fukuyama City Hospital
Sakurai, Jun
Department of Radiology, Kagawa Prefectural Central Hospital
Tajiri, Nobuhisa
Department of Radiology, Mitoyo General Hospital
Mukai, Takashi
Department of Radiology, Okayama Medical Center
Matsui, Yusuke
Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
|
抄録 | The application of radiofrequency ablation for the treatment of lung cancer by our group at Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences began in June 2001, and in the present report, we review our 10-year experience with this treatment modality at Okayama University Hospital. The local efficacy of radiofrequency ablation for the treatment of lung cancer depends on tumor size and the type of electrode used, but not on tumor type. An important factor for the prevention of local failure may be the acquisition of an adequate ablative margin. The combination of embolization and radiation therapy enhances the local efficacy. Local failure may be salvaged by repeating the radiofrequency ablation, particularly in small tumors. Survival rates after radiofrequency ablation are quite promising for patients with clinical stage I non-small cell lung cancer and pulmonary metastasis from colorectal cancer, hepatocellular carcinoma, and renal cell carcinoma. The complications caused by radiofrequency ablation can be treated conservatively in the majority of cases. However, attention should be paid to rare but serious complications. This review shows that radiofrequency ablation is a promising treatment for patients with lung cancer.
|
キーワード | radiofrequency ablation
lung cancer
local efficacy
survival
complication
|
Amo Type | Review
|
出版物タイトル |
Acta Medica Okayama
|
発行日 | 2011-10
|
巻 | 65巻
|
号 | 5号
|
出版者 | Okayama University Medical School
|
開始ページ | 287
|
終了ページ | 297
|
ISSN | 0386-300X
|
NCID | AA00508441
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
著作権者 | CopyrightⒸ 2011 by Okayama University Medical School
|
論文のバージョン | publisher
|
査読 |
有り
|
PubMed ID | |
Web of Science KeyUT |